यूरोपीय संघ - एस्टोनियाई - EMA (European Medicines Agency)

biocryst ireland limited - berotralstat dihydrochloride - angioödeem, pärilik - other hematological agents - orladeyo is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in adult and adolescent patients aged 12 years and older.

यूरोपीय संघ - एस्टोनियाई - EMA (European Medicines Agency)

laboratorios lesvi s.l. - dimetüülfumaraat - sclerosis multiplex, relapsing-remitting - immunosupressandid - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

एस्टोनिया - एस्टोनियाई - Ravimiamet

grindeks as - loperamiid - kõvakapsel - 2mg 10tk

एस्टोनिया - एस्टोनियाई - Ravimiamet

teva b.v. - tamsulosiin+dutasteriid - kõvakapsel - 0,4mg+0,5mg 7tk; 0,4mg+0,5mg 30tk; 0,4mg+0,5mg 90tk; 0,4mg+0,5mg 180tk

एस्टोनिया - एस्टोनियाई - Ravimiamet

g.l. pharma gmbh - tamsulosiin+dutasteriid - kõvakapsel - 0,4mg+0,5mg 90tk; 0,4mg+0,5mg 7tk; 0,4mg+0,5mg 30tk

यूरोपीय संघ - एस्टोनियाई - EMA (European Medicines Agency)

recordati netherlands b.v. - tivozaaniib - kartsinoom, neerurakk - antineoplastilised ained - fotivda on näidustatud valikraviks patsientidel kaugelearenenud neeru kartsinoom (rcc) ja täiskasvanud patsientidel, kes on vegfr ja mtor rada inhibiitor-ravi mittesaanud pärast haiguse progresseerumine pärast ühe eelnevalt tsütokiinravi selle täiustatud rcc. ravi kaugelearenenud neerurakuline vähk.

एस्टोनिया - एस्टोनियाई - Ravimiamet

mcneil healthcare (ireland) limited - loperamiid - suus dispergeeruv tablett - 2mg 20tk; 2mg 10tk; 2mg 6tk

एस्टोनिया - एस्टोनियाई - Ravimiamet

g.l. pharma gmbh - tamsulosiin - toimeainet modifitseeritult vabastav kõvakapsel - 0,4mg 14tk; 0,4mg 30tk; 0,4mg 200tk; 0,4mg 56tk; 0,4mg 50tk; 0,4mg 20tk; 0,4mg 60tk; 0,4mg 100tk

यूरोपीय संघ - एस्टोनियाई - EMA (European Medicines Agency)

pfizer limited - sunitiniib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastilised ained - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.

एस्टोनिया - एस्टोनियाई - Ravimiamet

sandoz pharmaceuticals d.d. - tamsulosiin+dutasteriid - kõvakapsel - 0,4mg+0,5mg 30tk; 0,4mg+0,5mg 7tk; 0,4mg+0,5mg 90tk